# The EVICEL® Neurosurgery Phase III Study

> **NCT02457546** · PHASE3 · COMPLETED · sponsor: **Ethicon, Inc.** · enrollment: 234 (actual)

## Conditions studied

- Cerebrospinal Fluid Leak

## Interventions

- **BIOLOGICAL:** EVICEL Fibrin Sealant
- **DEVICE:** Hydrogel sealant

## Key facts

- **NCT ID:** NCT02457546
- **Lead sponsor:** Ethicon, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07-01
- **Primary completion:** 2017-09-13
- **Final completion:** 2017-10-12
- **Target enrollment:** 234 (ACTUAL)
- **Last updated:** 2019-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02457546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02457546, "The EVICEL® Neurosurgery Phase III Study". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT02457546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*